Healthcare & Life Sciences
Crossbow Therapeutics
United States
series-b
series-b
Stage
1
Investors
About
Crossbow Therapeutics develops antibody-based cancer therapies designed to expand the range of targetable cancer antigens, aiming to create more potent and precise oncology treatments.
Explore Crossbow Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.